Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection
Condition: HER-2-positive Advanced Breast Cancer Interventions: Drug: GB221; Drug: Placebo control Sponsor: Genor Biopharma Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials